A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Aliment Pharmacol Ther
; 21(4): 373-84, 2005 Feb 15.
Article
de En
| MEDLINE
| ID: mdl-15709987
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Agents gastro-intestinaux
/
Maladie de Crohn
/
Anti-inflammatoires non stéroïdiens
/
Anticorps monoclonaux
Type d'étude:
Clinical_trials
Aspects:
Patient_preference
Limites:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Aliment Pharmacol Ther
Sujet du journal:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Année:
2005
Type de document:
Article
Pays d'affiliation:
Canada
Pays de publication:
Royaume-Uni